Overview

The Role of Mineralocorticoid Receptors in Vascular Function

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to figure out how decreasing the activity of 11-beta hydroxysteroid dehydrogenase (11-beta HSD) will affect your blood vessel function. 11-beta HSD, which is found in the kidneys and blood vessels, is a natural protein that when active helps to keep your blood pressure under control.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Glycyrrhetinic Acid
Mineralocorticoids
Criteria
Inclusion Criteria:

- Healthy volunteers

Exclusion Criteria:

- Blood pressure above 140/90

- Abnormal physical finding

- Blood test values for total and LDL cholesterol, CBC, sodium, potassium, creatinine,
and glucose laboratories greater 1.5 times normal